Lipid Parameters and the Development of Chronic Kidney Disease: A Prospective Cohort Study in Middle-Aged and Elderly Chinese Individuals

被引:6
作者
Liao, Shumei [1 ]
Lin, Diaozhu [1 ]
Feng, Qiling [1 ]
Li, Feng [1 ]
Qi, Yiqin [1 ]
Feng, Wanting [1 ]
Yang, Chuan [1 ]
Yan, Li [1 ]
Ren, Meng [1 ]
Sun, Kan [1 ]
机构
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Endocrinol, 107 Yanjiang West Rd, Guangzhou 510120, Peoples R China
基金
中国国家自然科学基金;
关键词
dyslipidemia; chronic kidney disease; urinary albumin-to-creatinine ratio; creatinine; estimated glomerular filtration rate; TG to HDL-C ratio; CARDIOVASCULAR EVENTS; DIABETIC INDIVIDUALS; APOLIPOPROTEIN-B; HDL-CHOLESTEROL; RISK-EVALUATION; DISORDERS; CANCERS;
D O I
10.3390/nu15010112
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Epidemiological evidence suggests that lipid parameters are related to the progression of chronic kidney disease (CKD). Nevertheless, prospective studies that comprehensively assess the effect of routinely available lipid measures on the development of CKD are lacking. The aim of this study was to longitudinally assess the influence of lipid metabolism indicators on the presence of CKD in a large community-based population. We conducted a prospective cohort study at Sun Yat-sen Memorial Hospital, China, with 5345 patients of 40 years or older. Cox regression models were conducted, and hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated to assess lipid parameters and their relationship with the incidence of CKD. During the follow-up period, 340 (6.4%) subjects developed CKD. The incidence of CKD increased progressively with quartile values of triglyceride (TG), the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (non-HDL-C/HDL-C) and the ratio of TG to HDL-C, but decreased with HDL-C quartiles (p < 0.0001 for all trends). Pearson's correlation analysis and multiple regression analyses indicated that these parameters were also associated with various indicators of kidney function. Moreover, we found that among all the lipid parameters, TG/HDL-C emerged as the most effective predictor of CKD. In conclusion, our findings suggest that TG/HDL-C better predicts the incidence of CKD in middle-aged and elderly Chinese individuals than other lipid parameters tested in the study.
引用
收藏
页数:11
相关论文
共 39 条
  • [1] Renal lipotoxicity: Insights from experimental models
    Abreu Castro, Barbara Bruna
    Foresto-Neto, Orestes
    Saraiva-Camara, Niels Olsen
    Sanders-Pinheiro, Helady
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2021, 48 (12) : 1579 - 1588
  • [2] Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD
    Bajaj, Archna
    Xie, Dawei
    Cedillo-Couvert, Esteban
    Charleston, Jeanne
    Chen, Jing
    Deo, Rajat
    Feldman, Harold, I
    Go, Alan S.
    He, Jiang
    Horwitz, Edward
    Kallem, Radhakrishna
    Rahman, Mahboob
    Weir, Matthew R.
    Anderson, Amanda H.
    Rader, Daniel J.
    Appel, Lawrence J.
    Kusek, John W.
    Lash, James P.
    Rao, Panduranga S.
    Townsend, Raymond R.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (06) : 827 - 836
  • [3] Cohort profile: Risk evaluation of cancers in Chinese diabetic individuals: A longitudinal (REACTION) study
    Bi, Yufang
    Lu, Jieli
    Wang, Weiqing
    Mu, Yiming
    Zhao, Jiajun
    Liu, Chao
    Chen, Lulu
    Shi, Lixin
    Li, Qiang
    Wan, Qin
    Wu, Shengli
    Yang, Tao
    Yan, Li
    Liu, Yan
    Wang, Guixia
    Luo, Zuojie
    Tang, Xulei
    Chen, Gang
    Huo, Yanan
    Gao, Zhengnan
    Su, Qing
    Ye, Zhen
    Wang, Youming
    Qin, Guijun
    Deng, Huacong
    Yu, Xuefeng
    Shen, Feixia
    Chen, Li
    Zhao, Liebin
    Zhang, Jie
    Sun, Jichao
    Dai, Meng
    Xu, Min
    Xu, Yu
    Chen, Yuhong
    Lai, Shenghan
    Bloomgarden, Zachary T.
    Li, Donghui
    Ning, Guang
    [J]. JOURNAL OF DIABETES, 2014, 6 (02) : 147 - 157
  • [4] Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
    Bikbov, Boris
    Purcell, Carrie
    Levey, Andrew S.
    Smith, Mari
    Abdoli, Amir
    Abebe, Molla
    Adebayo, Oladimeji M.
    Afarideh, Mohsen
    Agarwal, Sanjay Kumar
    Agudelo-Botero, Marcela
    Ahmadian, Elham
    Al-Aly, Ziyad
    Alipour, Vahid
    Almasi-Hashiani, Amir
    Al-Raddadi, Rajaa M.
    Alvis-Guzman, Nelson
    Amini, Saeed
    Andrei, Tudorel
    Andrei, Catalina Liliana
    Andualem, Zewudu
    Anjomshoa, Mina
    Arabloo, Jalal
    Ashagre, Alebachew Fasil
    Asmelash, Daniel
    Ataro, Zerihun
    Atout, Maha Moh'd Wahbi
    Ayanore, Martin Amogre
    Badawi, Alaa
    Bakhtiari, Ahad
    Ballew, Shoshana H.
    Balouchi, Abbas
    Banach, Maciej
    Barquera, Simon
    Basu, Sanjay
    Bayih, Mulat Tirfie
    Bedi, Neeraj
    Bello, Aminu K.
    Bensenor, Isabela M.
    Bijani, Ali
    Boloor, Archith
    Borzi, Antonio M.
    Camera, Luis Alberto
    Carrero, Juan J.
    Carvalho, Felix
    Castro, Franz
    Catala-Lopez, Ferran
    Chang, Alex R.
    Chin, Ken Lee
    Chung, Sheng-Chia
    Cirillo, Massimo
    [J]. LANCET, 2020, 395 (10225) : 709 - 733
  • [5] Disorders of Lipid Metabolism in Chronic Kidney Disease
    Bulbul, Mustafa C.
    Dagel, Tuncay
    Afsar, Baris
    Ulusu, Nuray N.
    Kuwabara, Masanarini
    Covic, Adrian
    Kanbay, Mehmet
    [J]. BLOOD PURIFICATION, 2018, 46 (02) : 144 - 152
  • [6] Prognostic significance of renal function in elderly patients with isolated Systolic hypertension:: Results from the Syst-eur trial
    De Leeuw, PW
    Thijs, L
    Birkenhäger, WH
    Voyaki, SM
    Efstratopoulos, AD
    Fagard, RH
    Leonetti, G
    Nachev, C
    Petrie, JC
    Rodicio, JL
    Rosenfeld, JJ
    Sarti, C
    Staessen, JA
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (09): : 2213 - 2222
  • [7] The effect of chronic kidney disease on lipid metabolism
    Dincer, Neris
    Dagel, Tuncay
    Afsar, Baris
    Covic, Adrian
    Ortiz, Alberto
    Kanbay, Mehmet
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (02) : 265 - 277
  • [8] Proteinuria and other markers of chronic kidney disease: A position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
    Eknoyan, G
    Hostetter, T
    Bakris, GL
    Hebert, L
    Levey, AS
    Parving, HH
    Steffes, MW
    Toto, R
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (04) : 617 - 622
  • [9] Lipid management in patients with chronic kidney disease
    Ferro, Charles J.
    Mark, Patrick B.
    Kanbay, Mehmet
    Sarafidis, Pantelis
    Heine, Gunnar H.
    Rossignol, Patrick
    Massy, Ziad A.
    Mallamaci, Francesca
    Valdivielso, Jose M.
    Malyszko, Jolanta
    Verhaar, Marianne C.
    Ekart, Robert
    Vanholder, Raymond
    London, Gerard
    Ortiz, Alberto
    Zoccali, Carmine
    [J]. NATURE REVIEWS NEPHROLOGY, 2018, 14 (12) : 727 - 749
  • [10] Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins
    Florens, Nans
    Calzada, Catherine
    Lyasko, Egor
    Juillard, Laurent
    Soulage, Christophe O.
    [J]. TOXINS, 2016, 8 (12)